Stockreport

EMA tags PhaseRx's lead product candidate an Orphan Drug for rare enzyme deficiency disorder; shares ahead 13% [Seeking Alpha]

PHASERX  (PZRX) 
US:NASDAQ Investor Relations: investor.phaserx.com/investors/default.aspx
PDF Thinly traded nano cap PhaseRx ( PZRX ) is up on a 34x surge in volume in response to the news that the European Medicines Agency has designated lead product [Read more]